Acrivon Therapeutics’ (ACRV) Hold Rating Reiterated at Jones Trading
Jones Trading reaffirmed their hold rating on shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) in a research report released on Friday morning,Benzinga reports. Other analysts have also recently issued reports about the stock. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Acrivon Therapeutics in a research note on Wednesday, March 26th. Oppenheimer lowered […]
Jones Trading reaffirmed their hold rating on shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) in a research report released on Friday morning,Benzinga reports. Other analysts have also recently issued reports about the stock. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Acrivon Therapeutics in a research note on Wednesday, March 26th. Oppenheimer lowered […]
